Simponi, Simponi Aria (golimumab) is an antibody pharmaceutical. Golimumab was first approved as Simponi on 2009-04-24. It is used to treat rheumatoid arthritis in the USA. It has been approved in Europe to treat ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. The pharmaceutical is active against tumor necrosis factor.
|Indication||ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis|
|Drug Class||Monoclonal antibodies|